These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 17514879)
1. Effect of epsilon-aminocaproylamino acids on fibrin formation. Bruzgo I; Midura-Nowaczek K; Bruzgo M; Kaczyńska J; Roszkowska-Jakimiec W Acta Pol Pharm; 2006; 63(2):149-52. PubMed ID: 17514879 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and activity of N epsilon-aminocaproyl-L-norleucine derivatives. Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K Acta Pol Pharm; 1996; 53(3):221-3. PubMed ID: 8960292 [TBL] [Abstract][Full Text] [Related]
3. Measurement of fibrinolytic activity after epsilon-aminocaproic acid administration in rats (Rattus norvegicus). Gogjian MA; Barry KJ; Stein BM Lab Anim Sci; 1981 Dec; 31(6):710-1. PubMed ID: 7343767 [TBL] [Abstract][Full Text] [Related]
4. The effect of some epsilon-aminocaproic acid derivatives on platelet responses. Bruzgo I; Tomasiak M; Stelmach H; Midura-Nowaczek K Acta Biochim Pol; 2004; 51(1):73-80. PubMed ID: 15094827 [TBL] [Abstract][Full Text] [Related]
5. Effects of epsilon-aminocaproiloaminoacids on the amidolytic activity of tissue plasminogen activator, urokinase and kallikrein. Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Markowska A Acta Pol Pharm; 2004; 61(1):75-6. PubMed ID: 15259861 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and activity of dipeptides containing epsilon-aminocaproic acid. Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K Acta Pol Pharm; 1994; 51(6):499-504. PubMed ID: 7762400 [TBL] [Abstract][Full Text] [Related]
8. Effect of epsilon-aminocaproyl-S-benzyl-L-cysteine on the activity of plasminogen activators. Bruzgo I; Midura-Nowaczek K; Kaczyńska J; Krajewska D Acta Pol Pharm; 2009; 66(1):37-40. PubMed ID: 19226966 [TBL] [Abstract][Full Text] [Related]
9. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots. Helle I Scand J Haematol Suppl; 1968; 4():1-46. PubMed ID: 4181525 [No Abstract] [Full Text] [Related]
10. [Effect of phosphatidylserine on formation and lysis of fibrin]. Byshevskiĭ ASh; Lapusova TM; Mukhacheva IA Vopr Med Khim; 1978; 24(4):510-4. PubMed ID: 150701 [TBL] [Abstract][Full Text] [Related]
11. Fibrin deposition in the ribbit kidney produced by protease inhibitors. Beller FK; Mitchell PS; Gorstein F Thromb Diath Haemorrh; 1967 May; 17(3-4):427-39. PubMed ID: 5301528 [No Abstract] [Full Text] [Related]
12. [Ultrasonic coagulometry as a method of testing compounds with antiplasmin activity]. Zabelin NN; Gribauskas PS; Moĭseenok AG Biofizika; 1988; 33(2):226-8. PubMed ID: 3390473 [TBL] [Abstract][Full Text] [Related]
13. Cytotoxic activity of epsilon-aminocaproylamino acids in breast cancer MCF-7 and fibroblast cell lines. Midura-Nowaczek K; Markowska A; Krajewska D; Wołczyński S Acta Pol Pharm; 2010; 67(2):201-4. PubMed ID: 20369798 [TBL] [Abstract][Full Text] [Related]
14. The effective concentration of epsilon-aminocaproic Acid for inhibition of fibrinolysis in neonatal plasma in vitro. Yurka HG; Wissler RN; Zanghi CN; Liu X; Tu X; Eaton MP; Anesth Analg; 2010 Jul; 111(1):180-4. PubMed ID: 20519417 [TBL] [Abstract][Full Text] [Related]
15. Influence of dipeptide derivatives of S-substituted cysteines on the time of fibrinolysis. Midura-Nowaczek K; Bruzgo I; Roszkowska-Jakimiec W; Worowski K Rocz Akad Med Bialymst; 1996; 41(2):412-6. PubMed ID: 9020554 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of coagulation and fibrinolysis by aromatic amidino compounds. An in vitro and in vivo study. Geratz JD Thromb Diath Haemorrh; 1971 Jun; 25(3):391-404. PubMed ID: 5314899 [No Abstract] [Full Text] [Related]
17. A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening. Kostka B; Para J; Sikora J Blood Coagul Fibrinolysis; 2007 Oct; 18(7):611-8. PubMed ID: 17890947 [TBL] [Abstract][Full Text] [Related]
18. Effect of epsilon-aminocaproylaminoacids on the activity of proteolytic enzymes. Bruzgo I; Midura-Nowaczek K; Roszkowska-Jakimiec W; Jasielczuk J Acta Pol Pharm; 2001; 58(2):137-40. PubMed ID: 11501792 [TBL] [Abstract][Full Text] [Related]
19. Short peptides containing L-lysine and epsilon-aminocaproic acid as potential plasmin inhibitors. Purwin M; Bruzgo I; Markowska A; Midura-Nowaczek K Pharmazie; 2009 Nov; 64(11):765-7. PubMed ID: 20099524 [TBL] [Abstract][Full Text] [Related]
20. The effect of epsilon-aminocaproic acid on HemoSTATUS and kaolin-activated clotting time measurements. Saleem R; Bigham M; Spitznagel E; Despotis GJ Anesth Analg; 2000 Jun; 90(6):1281-5. PubMed ID: 10825308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]